The pharmaceutical industry is aggressively evolving, with growing demand for high-quality Active Pharmaceutical Ingredients (APIs). Dulaglutide, a peptide hormone, is a key copyrightple of this trend. To fulfill this demand, US-based manufacturing services are emerging. These providers offer a wide-ranging suite of capabilities, from research and